82 related articles for article (PubMed ID: 31268904)
1. Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization.
Su ZD; Li CQ; Wang HW; Zheng MM; Chen QW
J Transl Med; 2023 Jun; 21(1):427. PubMed ID: 37386574
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL Disrupts Metabolism and Inhibits Macrophage Survival by Activating a miR-9/Drp1/Mitochondrial Fission Signaling Pathway.
Xin T; Lu C; Zhang J; Wen J; Yan S; Li C; Zhang F; Zhang J
Oxid Med Cell Longev; 2020; 2020():8848930. PubMed ID: 33204400
[TBL] [Abstract][Full Text] [Related]
3. Effects of fluoroquinolones and tetracyclines on mitochondria of human retinal MIO-M1 cells.
Salimiaghdam N; Singh L; Schneider K; Chwa M; Atilano SR; Nalbandian A; Limb GA; Kenney MC
Exp Eye Res; 2022 Jan; 214():108857. PubMed ID: 34856207
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein changes the inflammatory status and metabolomics profiles in human and mouse macrophages and microglia.
Sun Y; Liang JJ; Xu J; Zhou K; Fu C; Chen SL; Yang R; Ng TK; Liu Q; Zhang M
Heliyon; 2024 Apr; 10(7):e28806. PubMed ID: 38617955
[TBL] [Abstract][Full Text] [Related]
5. NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.
Wang Z; Tao E; Chen Y; Wang Q; Liu M; Wei L; Xu S; Chen W; Zhong C
Biochem Cell Biol; 2023 Dec; 101(6):523-530. PubMed ID: 37602474
[TBL] [Abstract][Full Text] [Related]
6. Carbonized polymer dots derived from metformin and L-arginine for tumor cell membrane- and mitochondria-dual targeting therapy.
Chen M; Li Y; Liu Y; Jia B; Liu X; Ma T
Nanoscale; 2023 Nov; 15(44):17922-17935. PubMed ID: 37902070
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation.
Pulipaka S; Singuru G; Sahoo S; Shaikh A; Thennati R; Kotamraju S
Geroscience; 2024 Apr; 46(2):2391-2408. PubMed ID: 37968424
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation.
Cortés M; Brischetto A; Martinez-Campanario MC; Ninfali C; Domínguez V; Fernández S; Celis R; Esteve-Codina A; Lozano JJ; Sidorova J; Garrabou G; Siegert AM; Enrich C; Pintado B; Morales-Ruiz M; Castro P; Cañete JD; Postigo A
Nat Commun; 2023 Nov; 14(1):7471. PubMed ID: 37978290
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759.
Pujalte-Martin M; Belaïd A; Bost S; Kahi M; Peraldi P; Rouleau M; Mazure NM; Bost F
Mol Oncol; 2024 Jan; ():. PubMed ID: 38214418
[TBL] [Abstract][Full Text] [Related]
10. Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
Wang Y; An H; Liu T; Qin C; Sesaki H; Guo S; Radovick S; Hussain M; Maheshwari A; Wondisford FE; O'Rourke B; He L
Cell Rep; 2019 Nov; 29(6):1511-1523.e5. PubMed ID: 31693892
[TBL] [Abstract][Full Text] [Related]
11. PCSK9 mediates the oxidative low‑density lipoprotein‑induced pyroptosis of vascular endothelial cells via the UQCRC1/ROS pathway.
Zeng J; Tao J; Xi L; Wang Z; Liu L
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576442
[TBL] [Abstract][Full Text] [Related]
12. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis.
Liu D; Wang X; Zhang M; Tian J; Liu M; Jin T; Pan J; Gao M; An F
J Cell Mol Med; 2020 Oct; 24(20):11729-11741. PubMed ID: 32851768
[TBL] [Abstract][Full Text] [Related]
13. Metformin improved oxidized low-density lipoprotein-impaired mitochondrial function and increased glucose uptake involving Akt-AS160 pathway in raw264.7 macrophages.
He X; Wang L; Chen XF; Liang Q; Wang WQ; Lin AQ; Yi L; Wang Y; Gao Q
Chin Med J (Engl); 2019 Jul; 132(14):1713-1722. PubMed ID: 31268904
[TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates Ox-LDL-induced foam cell formation in raw264.7 cells by promoting ABCG-1 mediated cholesterol efflux.
He X; Chen X; Wang L; Wang W; Liang Q; Yi L; Wang Y; Gao Q
Life Sci; 2019 Jan; 216():67-74. PubMed ID: 30218721
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oxidized low-density lipoprotein-affected macrophage efferocytosis by mitochondrial calcium uniporter in a murine model.
Lu N; Zhu JF; Lv HF; Zhang HP; Wang PL; Yang JJ; Wang XW
Immunol Lett; 2023 Nov; 263():14-24. PubMed ID: 37689315
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
[TBL] [Abstract][Full Text] [Related]
17. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
18. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes.
Nosadini R; Tonolo G
Nutr Metab Cardiovasc Dis; 2011 Feb; 21(2):79-85. PubMed ID: 21186102
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
